Clinical Trial

Deep EigenMatics Receives United States Patent for Inventing Breakthrough Artificial Intelligence Method for Protein Design and Drug Discovery

SUGAR LAND, Texas, Sept. 26, 2025 /PRNewswire/ -- Deep EigenMatics, a startup developing innovative Artificial Intelligence methods for drug discovery and…

3 months ago

CASI Pharmaceuticals Appoints James Huang to Board of Directors

- Industry veteran brings over 35 years of biotech experience as a successful entrepreneur and investor- Operating experience to significantly…

3 months ago

UPDATE — ADvantage Therapeutics Awarded $2.5 Million NIH SBIR Grant to Advance Alzheimer’s Drug Candidate AD04® Toward the Clinic

MIAMI, Sept. 26, 2025 (GLOBE NEWSWIRE) -- ADvantage Therapeutics, Inc., a biotechnology company developing novel therapies for neurodegenerative diseases, today…

3 months ago

MMJ’s FDA Cannabis Softgel Capsule Could Be the Real Game Changer for Huntington’s – Gene Therapy Sparks Hope

MMJ BioPharma Cultivation is completing its Cannabis DEA bulk manufacturing license process, a seven-year DEA battle that has delayed the…

3 months ago

Radicle Science Continues to Expand Executive Bench with Industry Leaders to Accelerate Growth

High impact leaders Bill Bae and Jaclyn Bowen, with expertise in strategy, innovation, consumer advocacy, certification, and global markets join…

3 months ago

Verismo Therapeutics Announces Partnership with Miltenyi Biotec to Support Advancing Clinical Programs

Miltenyi Bioindustry division to supply commercial-ready lentiviral vector to support STAR-101 clinical trial PHILADELPHIA, Sept. 25, 2025 /PRNewswire/ -- Verismo Therapeutics,…

3 months ago

Primum Health Raises Seed Round Led by FCA Venture Partners and North Coast Ventures

Funding will fuel rapid expansion of the Columbus-based oncology platform, which connects community oncologists with subspecialty experts and real-world insights…

3 months ago

Femasys Accelerates European Growth for FemBloc® with Kebomed Partnership

-- Femasys leverages Kebomed’s pan-European distribution strength to drive adoption of FemBloc permanent birth control in France and Benelux, unlocking…

3 months ago

Silexion Therapeutics Regains Compliance with Nasdaq Listing Requirements

Company Successfully Meets Both Minimum Bid Price and Shareholders' Equity Requirements, Securing Continued Listing on the Nasdaq Capital MarketGRAND CAYMAN,…

3 months ago

AIM ImmunoTech Secures Patent in Japan Through 2039 for Novel Cancer Therapy Combining Ampligen® (Rintatolimod) with Checkpoint Inhibitors

Patent supports AIM’s strategy to expand international market protection, providing opportunities for licensing, collaborations, and long-term revenue growth Japan is…

3 months ago